Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Jubilant Pharmova Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 16, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	149,423	129,323	141,360	90,432	44,418	61,740
Market Cap Growth	-12.56%	-8.52%	56.32%	103.60%	-28.06%	-43.03%
Enterprise Value	172,927	151,721	161,255	117,283	70,881	82,624
Last Close Price	935.80	812.24	887.49	561.29	271.25	372.17

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 16, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	42.14	32.45	16.84	117.29	-	14.92
PS Ratio	1.72	1.56	1.95	1.35	0.71	1.01
PB Ratio	2.09	1.82	2.27	1.67	0.82	1.16
P/TBV Ratio	4.96	4.33	5.40	4.69	2.20	2.87
P/FCF Ratio	-	-	-	122.87	-	25.99
P/OCF Ratio	12.09	10.54	13.19	9.31	6.72	7.37

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 16, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	2.00	1.83	2.23	1.75	1.13	1.35
EV/EBITDA Ratio	15.22	13.53	15.34	14.78	10.97	7.75
EV/EBIT Ratio	22.96	18.52	19.99	22.42	18.91	9.84
EV/FCF Ratio	-	-	-	159.35	-	34.78

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 16, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.51	0.51	0.44	0.68	0.68	0.60
Debt / EBITDA Ratio	3.20	3.05	2.45	4.31	5.18	2.82
Debt / FCF Ratio	-	-	-	49.78	-	13.44
Net Debt / Equity Ratio	0.33	0.33	0.26	0.50	0.49	0.41
Net Debt / EBITDA Ratio	2.20	2.09	1.56	3.41	4.12	2.07
Net Debt / FCF Ratio	-	-10.56	-37.76	36.79	-17.31	9.27
Asset Turnover	-	0.59	0.60	0.59	0.59	0.65
Inventory Turnover	-	2.40	2.07	1.73	1.54	1.23
Quick Ratio	-	1.07	1.03	1.18	1.26	1.34
Current Ratio	-	1.62	1.65	2.05	2.12	2.21
Return on Equity (ROE)	-	5.96%	14.34%	1.34%	-1.21%	8.21%
Return on Assets (ROA)	-	3.62%	4.15%	2.88%	2.22%	5.55%
Return on Invested Capital (ROIC)	5.10%	6.12%	8.60%	2.76%	-11.24%	7.64%
Return on Capital Employed (ROCE)	-	6.30%	7.60%	5.40%	4.00%	10.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 16, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.37%	3.08%	5.94%	0.85%	-1.37%	6.70%
FCF Yield	-1.50%	-1.72%	-0.31%	0.81%	-3.46%	3.85%
Dividend Yield	0.53%	0.61%	0.56%	0.88%	1.79%	1.29%
Payout Ratio	22.55%	19.95%	9.48%	103.50%	-	19.34%
Buyback Yield / Dilution	0.04%	-0.01%	-0.01%	0.18%	0.02%	0.06%
Total Shareholder Return	0.57%	0.60%	0.55%	1.06%	1.81%	1.35%

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error